期刊文献+

真实临床条件下Cypher^(TM)支架的应用效果评价 被引量:10

Effect of Sirolimus-eluting stent in actual clinical practice
暂未订购
导出
摘要 目的 观察在真实临床条件(realworld)下使用西罗莫司(雷帕霉素)药物CypherTM 支架的疗效。方法 入选我科自2 0 0 2年1 2月至2 0 0 4年5月所有应用CypherTM 支架的患者,共2 6 3例,于支架置入后8±2个月,电话及门诊随访应用药物洗脱支架患者的主要不良心脏事件发生率;评价糖尿病亚组及各种类型病变(包括左主干病变、分叉病变、慢性闭塞病变、钙化病变、开口病变、小血管病变、急性闭塞病变及再狭窄病变)的治疗效果。结果 2 6 3例患者支架置入成功率为1 0 0 % ;随访2 4 6例,失访1 7例,随访率93 5% ;主要不良心脏事件有1 0例,发生率为3 8% ;复查冠状动脉造影1 39例,支架内再狭窄率为1 0 1 % ,其中糖尿病亚组为1 2 . 9% ,弥漫病变为1 0 . 0 % ,开口病变6 9% ,慢性闭塞病变1 1 . 1 % ,小血管病变1 1 . 3% ,急性闭塞病变0 ,钙化病变9 1 % ,A型病变8 7% ,左主干病变2 2 . 2 % ,分叉病变1 8 .8% ,再狭窄病变1 1 . 1 %。结论 在真实临床状态下,CypherTM 支架可以明显减少糖尿病患者弥漫病变,急、慢性闭塞病变,小血管病变,开口病变,钙化病变,A型病变等主要不良心脏事件的发生。对于左主干病变、分叉病变和再狭窄病变,提示有益的疗效,临床疗效需进一步观察。 Objective To sbserve the effect of sirolimus-eluting stent in actual clinical practice. Methods The study included 263 patients who had implanted the cypher stents from December 2002 to May 2004. The incidence of MACE was followed up in all patients 8±2 months after stent implantation by means of telephone or out-patient department visit. Evaluation of the therapeutic effect was also made in the diabetes subgroup and different types of lesions, including left main, bifurcation, chronic total occlusion, diffuse disease, in-stent restenosis, littlie vessel, acute occlusion, ostial lesions, and just A-type lesions. The rate of restenosis was observed in all of the lesion. Results Among 246 patients, all patients were successfully implanted with the cypher stents, 93.5% patients had been followed up, 10 (3.8%) patients had MACE. 139 (52.6%) patient were revised by angiography. The total rate of restenosis was 10.1%, and among it 12.9% was diabetes mellitus patients, 11.1% with chronic total occlusion, 11.3% with little vessel lesion, 10.0% with diffuse lesion, 22.2% with left main lesion, 18.1% with bifurcation, 11.1 with CTO 9.1% with ostial lesions, and 8.7% with A-type lesion lesion. Conclusion Cypher stent implantion was safe and effective in actual clinical proctice. The incidence rate of MACE was low in lesions such as chronic total occlusion, diffuse disease, in-stent restenosis, littlie vessel, acute occlusion, ostial lesions, and A-type lesion. It may be beneficial for patients who had left main, bifurcation, in-stent restenosis.
出处 《中国介入心脏病学杂志》 2005年第2期67-70,共4页 Chinese Journal of Interventional Cardiology
  • 相关文献

参考文献9

  • 1陈纪林,高润霖,杨跃进,乔树宾,秦学文,姚民,刘海波,吴永健,袁晋青,陈珏,徐波.雷帕霉素药物洗脱支架在冠心病复杂病变中应用的近远期疗效[J].中华心血管病杂志,2004,32(10):867-869. 被引量:28
  • 2Colombo A, Moses JW, Morice MC, et al. Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions. Circulation, 2004, 109: 1244-1249.
  • 3Tanabe K, Hoye A, Lemos PA, el al. Restonosis rates following bifurcation stenting with sirolimus-eluting stents for De Novo narrowings. Am J Cardiol, 2004,91 : 115-118.
  • 4Smith SC, Dove JT, Kennedy JW, et al. ACC/AHA guidelines of percutaneous coronary interventions (revision of the 1993 PICA guidelines-executive summary). A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee to revise, the 1993 guidelines for percutaneous transluminal coronary angioplasty). J Am Coil Cardiol, 2001,37:2215-2239.
  • 5Ong AT, Aoki J, Mcfadden EP, et al. Classitication and current treatment options of in-stent restenoses. Present status and future perspectives. Herz, 2004,29: 187-194.
  • 6Leon MB, T eirstein PS, Moses JW, et al. Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenoses after stenting. N Eng J Med, 2001,344:250-256.
  • 7Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenoses in a native coronary artery. N Eng J Med, 2003,349: 1315-1323.
  • 8Lemos PA, Serruys PW, van Domburg RT, et al. Unrestricted utilization of sirlimus-eluting stents compared with conventional bare stent implantation in the real world: the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (REASERCH) Registry.Circulation, 2004,109; 190-195.
  • 9Thomas TS, Williams DO, Most AS. Efficacy of coronary, angioplasty of bifurcation lesions : Immediate and late outcome. Circulation, 1988,78 :254-632.

二级参考文献4

  • 1Morice MC, Serruys PW, Sousa JE, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med,2002, 346:1773-1780.
  • 2Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med, 2003, 349:1315-1323.
  • 3Schofer J, Schluter M, Gershlick AH, et al. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS). Lancet, 2003, 362:1093-1099.
  • 4Sousa JE, Costa MA, Sousa AG, et al. Two-year angiographic and intravascular ultrasound follow-up after implantation of sirolimus-eluting stents in human coronary arteries. Circulation, 2003, 107:381-383.

共引文献27

同被引文献81

引证文献10

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部